{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T06:55:46Z","timestamp":1766386546868,"version":"3.48.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Doctoral Research Initiation Fund of First Affiliated Hospital of Gannan Medical University","award":["DQ050"],"award-info":[{"award-number":["DQ050"]}]},{"name":"Science and Technology Program of Ganzhou Science and Technology Bureau","award":["NO.GZ2023ZSF084 and NO.GZ2024YLJ147"],"award-info":[{"award-number":["NO.GZ2023ZSF084 and NO.GZ2024YLJ147"]}]},{"name":"the Science and Technology Project of Health Commission of Jiangxi Province","award":["202410332"],"award-info":[{"award-number":["202410332"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-025-04257-z","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T06:53:54Z","timestamp":1766386434000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FUBP3 mediates MXI1 stability to silence RRAS and hinder MAPK signaling in acute megakaryoblastic leukemia progression"],"prefix":"10.1007","volume":"75","author":[{"given":"Ying","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiqiang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhirui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanrong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huixi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhipeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junsong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"4257_CR1","doi-asserted-by":"publisher","first-page":"6470","DOI":"10.1128\/MCB.21.19.6470-6483.2001","volume":"21","author":"JM Amann","year":"2001","unstructured":"Amann JM et al (2001) ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol Cell Biol 21:6470\u20136483. https:\/\/doi.org\/10.1128\/MCB.21.19.6470-6483.2001","journal-title":"Mol Cell Biol"},{"key":"4257_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1158\/1541-7786.MCR-05-0250","volume":"4","author":"S Borghini","year":"2006","unstructured":"Borghini S, Vargiolu M, Di Duca M, Ravazzolo R, Ceccherini I (2006) Nuclear factor Y drives basal transcription of the human TLX3, a gene overexpressed in T-cell acute lymphocytic leukemia. Mol Cancer Res 4:635\u2013643. https:\/\/doi.org\/10.1158\/1541-7786.MCR-05-0250","journal-title":"Mol Cancer Res"},{"key":"4257_CR3","doi-asserted-by":"publisher","unstructured":"Brouwer N et al. (2022) Immunophenotypic Analysis of Acute Megakaryoblastic Leukemia: A EuroFlow Study Cancers (Basel) 14 https:\/\/doi.org\/10.3390\/cancers14061583","DOI":"10.3390\/cancers14061583"},{"key":"4257_CR4","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.7150\/ijms.96627","volume":"21","author":"J Chen","year":"2024","unstructured":"Chen J et al (2024) Analysis of prognostic biomarker models of TXNIP\/NLRP3\/IL1B inflammasome pathway in patients with acute myeloid leukemia. Int J Med Sci 21:1438\u20131446. https:\/\/doi.org\/10.7150\/ijms.96627","journal-title":"Int J Med Sci"},{"key":"4257_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade5111","volume":"9","author":"JW Cheu","year":"2023","unstructured":"Cheu JW et al (2023) Hypoxia-inducible factor orchestrates adenosine metabolism to promote liver cancer development. Sci Adv 9:eade5111. https:\/\/doi.org\/10.1126\/sciadv.ade5111","journal-title":"Sci Adv"},{"key":"4257_CR6","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41586-018-0615-z","volume":"562","author":"M Deng","year":"2018","unstructured":"Deng M et al (2018) LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration. Nature 562:605\u2013609. https:\/\/doi.org\/10.1038\/s41586-018-0615-z","journal-title":"Nature"},{"key":"4257_CR7","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1093\/hmg\/ddu148","volume":"23","author":"E Flex","year":"2014","unstructured":"Flex E et al (2014) Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis. Hum Mol Genet 23:4315\u20134327. https:\/\/doi.org\/10.1093\/hmg\/ddu148","journal-title":"Hum Mol Genet"},{"key":"4257_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e35940","volume":"10","author":"Y Guo","year":"2024","unstructured":"Guo Y et al (2024) Deciphering the predictive value of senescence-related signature in lung adenocarcinoma: implications for antitumor immunity and immunotherapy efficacy. Heliyon 10:e35940. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35940","journal-title":"Heliyon"},{"key":"4257_CR9","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1182\/blood-2003-01-0013","volume":"101","author":"JK Hitzler","year":"2003","unstructured":"Hitzler JK, Cheung J, Li Y, Scherer SW, Zipursky A (2003) GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome. Blood 101:4301\u20134304. https:\/\/doi.org\/10.1182\/blood-2003-01-0013","journal-title":"Blood"},{"key":"4257_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cells13100864","author":"M Ho","year":"2024","unstructured":"Ho M, Bonavida B (2024) Cross-talks between Raf kinase inhibitor protein and programmed cell death ligand 1 expressions in cancer: role in immune evasion and therapeutic implications. Cells. https:\/\/doi.org\/10.3390\/cells13100864","journal-title":"Cells"},{"key":"4257_CR11","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41418-020-00616-8","volume":"28","author":"Y Huang","year":"2021","unstructured":"Huang Y et al (2021) UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance. Cell Death Differ 28:671\u2013684. https:\/\/doi.org\/10.1038\/s41418-020-00616-8","journal-title":"Cell Death Differ"},{"key":"4257_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.semcancer.2006.07.009","volume":"16","author":"PJ Hurlin","year":"2006","unstructured":"Hurlin PJ, Huang J (2006) The MAX-interacting transcription factor network. Semin Cancer Biol 16:265\u2013274. https:\/\/doi.org\/10.1016\/j.semcancer.2006.07.009","journal-title":"Semin Cancer Biol"},{"key":"4257_CR13","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3324\/haematol.2022.280801","volume":"108","author":"S Kayser","year":"2023","unstructured":"Kayser S, Levis MJ (2023) The clinical impact of the molecular landscape of acute myeloid leukemia. Haematologica 108:308\u2013320. https:\/\/doi.org\/10.3324\/haematol.2022.280801","journal-title":"Haematologica"},{"key":"4257_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.semcancer.2019.11.011","volume":"65","author":"Y Kobayashi","year":"2020","unstructured":"Kobayashi Y, Lim SO, Yamaguchi H (2020) Oncogenic signaling pathways associated with immune evasion and resistance to immune checkpoint inhibitors in cancer. Semin Cancer Biol 65:51\u201364. https:\/\/doi.org\/10.1016\/j.semcancer.2019.11.011","journal-title":"Semin Cancer Biol"},{"key":"4257_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2024.110942","volume":"116","author":"X Kong","year":"2024","unstructured":"Kong X et al (2024) Multi-omics analysis reveals a pericyte-associated gene expression signature for predicting prognosis and therapeutic responses in solid cancers. Genomics 116:110942. https:\/\/doi.org\/10.1016\/j.ygeno.2024.110942","journal-title":"Genomics"},{"key":"4257_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1170622","volume":"11","author":"J Li","year":"2023","unstructured":"Li J, Kalev-Zylinska ML (2023) Advances in molecular characterization of pediatric acute megakaryoblastic leukemia not associated with Down syndrome; impact on therapy development. Front Cell Dev Biol 11:1170622. https:\/\/doi.org\/10.3389\/fcell.2023.1170622","journal-title":"Front Cell Dev Biol"},{"key":"4257_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-022-02661-x","volume":"22","author":"J Li","year":"2022","unstructured":"Li J, Zhang Z, Guo K, Wu S, Guo C, Zhang X, Wang Z (2022) Identification of a key glioblastoma candidate gene, FUBP3, based on weighted gene co-expression network analysis. BMC Neurol 22:139. https:\/\/doi.org\/10.1186\/s12883-022-02661-x","journal-title":"BMC Neurol"},{"issue":"3","key":"4257_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00109-020-02011-9","volume":"99","author":"N Liu","year":"2021","unstructured":"Liu N, Wu Y, Wen X, Li P, Lu F, Shang H (2021) &lt;article-title update=\"added\"&gt;Chronic stress promotes acute myeloid leukemia progression through HMGB1\/NLRP3\/IL-1\u03b2 signaling pathway. J Mol Med (Berl) 99(3):403\u2013414. https:\/\/doi.org\/10.1007\/s00109-020-02011-9","journal-title":"J Mol Med (Berl)"},{"key":"4257_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2017.06.003","volume":"403","author":"WN Liu","year":"2017","unstructured":"Liu WN, Yan M, Chan AM (2017) A thirty-year quest for a role of R-Ras in cancer: from an oncogene to a multitasking GTPase. Cancer Lett 403:59\u201365. https:\/\/doi.org\/10.1016\/j.canlet.2017.06.003","journal-title":"Cancer Lett"},{"key":"4257_CR20","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1007\/s13402-024-00959-1","volume":"47","author":"Y Liu","year":"2024","unstructured":"Liu Y et al (2024) HVEM in acute lymphocytic leukemia facilitates tumour immune escape by inhibiting CD8(+) T cell function. Cell Oncol (Dordr) 47:1779\u20131796. https:\/\/doi.org\/10.1007\/s13402-024-00959-1","journal-title":"Cell Oncol (Dordr)"},{"key":"4257_CR21","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.trecan.2017.07.003","volume":"3","author":"CK Lopez","year":"2017","unstructured":"Lopez CK, Malinge S, Gaudry M, Bernard OA, Mercher T (2017) Pediatric acute megakaryoblastic leukemia: multitasking fusion proteins and oncogenic cooperations. Trends Cancer 3:631\u2013642. https:\/\/doi.org\/10.1016\/j.trecan.2017.07.003","journal-title":"Trends Cancer"},{"key":"4257_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/biom13101555","author":"A Martin-Vega","year":"2023","unstructured":"Martin-Vega A, Cobb MH (2023) Navigating the ERK1\/2 MAPK cascade. Biomolecules. https:\/\/doi.org\/10.3390\/biom13101555","journal-title":"Biomolecules"},{"key":"4257_CR23","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.critrevonc.2019.04.011","volume":"138","author":"R Masetti","year":"2019","unstructured":"Masetti R, Guidi V, Ronchini L, Bertuccio NS, Locatelli F, Pession A (2019) The changing scenario of non-Down syndrome acute megakaryoblastic leukemia in children. Crit Rev Oncol Hematol 138:132\u2013138. https:\/\/doi.org\/10.1016\/j.critrevonc.2019.04.011","journal-title":"Crit Rev Oncol Hematol"},{"key":"4257_CR24","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a034884","author":"M McNulty","year":"2020","unstructured":"McNulty M, Crispino JD (2020) Acute megakaryocytic leukemia. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a034884","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4257_CR25","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00262-006-0205-z","volume":"56","author":"N Mora","year":"2007","unstructured":"Mora N, Rosales R, Rosales C (2007) R-Ras promotes metastasis of cervical cancer epithelial cells. Cancer Immunol Immunother 56:535\u2013544. https:\/\/doi.org\/10.1007\/s00262-006-0205-z","journal-title":"Cancer Immunol Immunother"},{"key":"4257_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-024-01837-5","volume":"12","author":"M Motevasseli","year":"2024","unstructured":"Motevasseli M et al (2024) Distinct tumor-TAM interactions in IDH-stratified glioma microenvironments unveiled by single-cell and spatial transcriptomics. Acta Neuropathol Commun 12:133. https:\/\/doi.org\/10.1186\/s40478-024-01837-5","journal-title":"Acta Neuropathol Commun"},{"key":"4257_CR27","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1093\/nar\/26.12.2899","volume":"26","author":"GE Muscat","year":"1998","unstructured":"Muscat GE, Burke LJ, Downes M (1998) &lt;article-title update=\"modified\" original=\"The corepressor N-CoR and its variants RIP13a and RIP13Delta1 directly interact with the basal transcription factors TFIIB, TAFII32 and TAFII70\"&gt;The corepressor N-CoR and its variants RIP13a and RIP13\u00a01 directly interact with the basal transcription factors TFIIB, TAFII32 and TAFII70. Nucleic Acids Res 26:2899\u20132907. https:\/\/doi.org\/10.1093\/nar\/26.12.2899","journal-title":"Nucleic Acids Res"},{"key":"4257_CR28","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1080\/10428194.2023.2190432","volume":"64","author":"MK Mustafa Ali","year":"2023","unstructured":"Mustafa Ali MK, Williams MT, Corley EM, AlKaabba F, Niyongere S (2023) Impact of KRAS and NRAS mutations on outcomes in acute myeloid leukemia. Leuk Lymphoma 64:962\u2013971. https:\/\/doi.org\/10.1080\/10428194.2023.2190432","journal-title":"Leuk Lymphoma"},{"key":"4257_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05357-9","volume":"13","author":"J Ren","year":"2022","unstructured":"Ren J et al (2022) Targeted activation of GPER enhances the efficacy of venetoclax by boosting leukemic pyroptosis and CD8+ T cell immune function in acute myeloid leukemia. Cell Death Dis 13:915. https:\/\/doi.org\/10.1038\/s41419-022-05357-9","journal-title":"Cell Death Dis"},{"key":"4257_CR30","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1158\/0008-5472.CAN-23-3553","volume":"84","author":"D Schmidt","year":"2024","unstructured":"Schmidt D et al (2024) &lt;article-title update=\"added\"&gt;Oncogenic calreticulin induces immune escape by stimulating TGF\u03b2 expression and regulatory T-cell expansion in the bone marrow microenvironment. Cancer Res 84:2985\u20133003. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-3553","journal-title":"Cancer Res"},{"key":"4257_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010624","author":"KS Shan","year":"2024","unstructured":"Shan KS, Rehman TU, Ivanov S, Domingo G, Raez LE (2024) Molecular targeting of the BRAF proto-oncogene\/mitogen-activated protein kinase (MAPK) pathway across cancers. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25010624","journal-title":"Int J Mol Sci"},{"key":"4257_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/jcmm.17584","volume":"27","author":"M Sharma","year":"2023","unstructured":"Sharma M, Anandram S, Ross C, Srivastava S (2023) FUBP3 regulates chronic myeloid leukaemia progression through PRC2 complex regulated PAK1-ERK signalling. J Cell Mol Med 27:15\u201329. https:\/\/doi.org\/10.1111\/jcmm.17584","journal-title":"J Cell Mol Med"},{"key":"4257_CR33","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ajh.26822","volume":"98","author":"S Shimony","year":"2023","unstructured":"Shimony S, Stahl M, Stone RM (2023) Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol 98:502\u2013526. https:\/\/doi.org\/10.1002\/ajh.26822","journal-title":"Am J Hematol"},{"key":"4257_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s11658-024-00546-0","volume":"29","author":"A Talajic","year":"2024","unstructured":"Talajic A, Dominko K, Loncaric M, Ambriovic-Ristov A, Cetkovic H (2024) The ancestral type of the R-RAS protein has oncogenic potential. Cell Mol Biol Lett 29:27. https:\/\/doi.org\/10.1186\/s11658-024-00546-0","journal-title":"Cell Mol Biol Lett"},{"key":"4257_CR35","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1182\/blood.2023019961","volume":"143","author":"J Vadakekolathu","year":"2024","unstructured":"Vadakekolathu J, Rutella S (2024) Escape from T-cell-targeting immunotherapies in acute myeloid leukemia. Blood 143:2689\u20132700. https:\/\/doi.org\/10.1182\/blood.2023019961","journal-title":"Blood"},{"key":"4257_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.867443","volume":"13","author":"DFT Veiga","year":"2022","unstructured":"Veiga DFT et al (2022) Monoallelic Heb\/Tcf12 deletion reduces the requirement for NOTCH1 hyperactivation in T-cell acute lymphoblastic leukemia. Front Immunol 13:867443. https:\/\/doi.org\/10.3389\/fimmu.2022.867443","journal-title":"Front Immunol"},{"issue":"369\u2013384","key":"4257_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.01.010","volume":"35","author":"E Wang","year":"2019","unstructured":"Wang E et al (2019) Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia. Cancer Cell 35(369\u2013384):e367. https:\/\/doi.org\/10.1016\/j.ccell.2019.01.010","journal-title":"Cancer Cell"},{"key":"4257_CR38","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1158\/0008-5472.CAN-20-0132","volume":"80","author":"L Xiao","year":"2020","unstructured":"Xiao L, Li X, Mu Z, Zhou J, Zhou P, Xie C, Jiang S (2020) FTO inhibition enhances the antitumor effect of temozolomide by targeting MYC-miR-155\/23a cluster-MXI1 feedback circuit in glioma. Cancer Res 80:3945\u20133958. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-0132","journal-title":"Cancer Res"},{"key":"4257_CR39","doi-asserted-by":"publisher","first-page":"12275","DOI":"10.18632\/aging.205179","volume":"15","author":"Z Xiao","year":"2023","unstructured":"Xiao Z et al (2023) Identification of M5c regulator-medicated methylation modification patterns for prognosis and immune microenvironment in glioma. Aging Albany NY 15:12275\u201312295. https:\/\/doi.org\/10.18632\/aging.205179","journal-title":"Aging Albany NY"},{"key":"4257_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215594","volume":"532","author":"X Yang","year":"2022","unstructured":"Yang X et al (2022) Arginine methyltransferase PRMT5 methylates and destabilizes Mxi1 to confer radioresistance in non-small cell lung cancer. Cancer Lett 532:215594. https:\/\/doi.org\/10.1016\/j.canlet.2022.215594","journal-title":"Cancer Lett"},{"key":"4257_CR41","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1182\/blood.2021012519","volume":"139","author":"X You","year":"2022","unstructured":"You X et al (2022) Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformation. Blood 139:1066\u20131079. https:\/\/doi.org\/10.1182\/blood.2021012519","journal-title":"Blood"},{"key":"4257_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-016-0084-8","volume":"6","author":"C Yu","year":"2016","unstructured":"Yu C, Zeng J, Yan Z, Ma Z, Liu S, Huang Z (2016) Baicalein antagonizes acute megakaryoblastic leukemia in vitro and in vivo by inducing cell cycle arrest. Cell Biosci 6:20. https:\/\/doi.org\/10.1186\/s13578-016-0084-8","journal-title":"Cell Biosci"},{"key":"4257_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj1578","volume":"13","author":"X Yu","year":"2021","unstructured":"Yu X et al (2021) A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models. Sci Transl Med 13:eabj1578. https:\/\/doi.org\/10.1126\/scitranslmed.abj1578","journal-title":"Sci Transl Med"},{"key":"4257_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3594","volume":"26","author":"Y Yu","year":"2024","unstructured":"Yu Y et al (2024) USP31 serves as a potential biomarker for predicting prognosis and immune responses for clear cell renal cell carcinoma via single-cell and bulk RNA-sequencing. J Gene Med 26:e3594. https:\/\/doi.org\/10.1002\/jgm.3594","journal-title":"J Gene Med"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04257-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-025-04257-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04257-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T06:53:56Z","timestamp":1766386436000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-025-04257-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["4257"],"URL":"https:\/\/doi.org\/10.1007\/s00262-025-04257-z","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal experiments conducted in this study were performed in compliance with the ethical standards and regulations set forth by the Institutional Animal Care and Use Committee (IACUC) of First Affiliated Hospital of Gannan Medical University (approval no. 2025091).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"23"}}